110 related articles for article (PubMed ID: 10597287)
1. Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro.
Li H; Cao Y; Berndt MC; Funder JW; Liu JP
Oncogene; 1999 Nov; 18(48):6785-94. PubMed ID: 10597287
[TBL] [Abstract][Full Text] [Related]
2. Immortalization of human mammary epithelial cells transfected with mutant p53 (273his).
Gollahon LS; Shay JW
Oncogene; 1996 Feb; 12(4):715-25. PubMed ID: 8632893
[TBL] [Abstract][Full Text] [Related]
3. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
[TBL] [Abstract][Full Text] [Related]
4. TERT regulates cell survival independent of telomerase enzymatic activity.
Cao Y; Li H; Deb S; Liu JP
Oncogene; 2002 May; 21(20):3130-8. PubMed ID: 12082628
[TBL] [Abstract][Full Text] [Related]
5. Telomerase-immortalized human fibroblasts retain UV-induced mutagenesis and p53-mediated DNA damage responses.
Porter PC; Clark DR; McDaniel LD; McGregor WG; States JC
DNA Repair (Amst); 2006 Jan; 5(1):61-70. PubMed ID: 16140041
[TBL] [Abstract][Full Text] [Related]
6. Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53.
Helps NR; Barker HM; Elledge SJ; Cohen PT
FEBS Lett; 1995 Dec; 377(3):295-300. PubMed ID: 8549741
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal end fusion resulting from telomere erosion increases susceptibility to radiation via multinucleation: effect of p53.
Ju YJ; Park JE; Juhn KM; Jeong J; Yun M; Park MJ; Park GH; Choi KY; Cho MH; Wong KK; Park WB; Lee KH
Int J Oncol; 2006 Oct; 29(4):753-63. PubMed ID: 16964373
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells.
Yang G; Rosen DG; Mercado-Uribe I; Colacino JA; Mills GB; Bast RC; Zhou C; Liu J
Carcinogenesis; 2007 Jan; 28(1):174-82. PubMed ID: 16829690
[TBL] [Abstract][Full Text] [Related]
9. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
[TBL] [Abstract][Full Text] [Related]
10. Reduction in mortalin level by its antisense expression causes senescence-like growth arrest in human immortalized cells.
Wadhwa R; Takano S; Taira K; Kaul SC
J Gene Med; 2004 Apr; 6(4):439-44. PubMed ID: 15079818
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
Xu D; Wang Q; Gruber A; Björkholm M; Chen Z; Zaid A; Selivanova G; Peterson C; Wiman KG; Pisa P
Oncogene; 2000 Oct; 19(45):5123-33. PubMed ID: 11064449
[TBL] [Abstract][Full Text] [Related]
12. A cellular protein activates the sequence-specific DNA-binding of p53 by interacting with the central conserved region.
Srinivasan R; Maxwell SA
Oncogene; 1996 Jan; 12(1):193-200. PubMed ID: 8552392
[TBL] [Abstract][Full Text] [Related]
13. Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase.
Vaziri H; Benchimol S
Oncogene; 1999 Dec; 18(53):7676-80. PubMed ID: 10618707
[TBL] [Abstract][Full Text] [Related]
14. Specific binding of MAR/SAR DNA-elements by mutant p53.
Müller BF; Paulsen D; Deppert W
Oncogene; 1996 May; 12(9):1941-52. PubMed ID: 8649855
[TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanisms involved in the regulation of telomerase activity].
Liu WJ; Ding J
Sheng Li Ke Xue Jin Zhan; 2001 Jul; 32(3):220-4. PubMed ID: 12545793
[TBL] [Abstract][Full Text] [Related]
16. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
17. Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16.
Johnstone RW; Wei W; Greenway A; Trapani JA
Oncogene; 2000 Dec; 19(52):6033-42. PubMed ID: 11146555
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the specific DNA binding activity of Xenopus laevis p53: evidence for conserved regulation through the carboxy-terminus of the protein.
Bessard AC; Garay E; Lacronique V; Legros Y; Demarquay C; Houque A; Portefaix JM; Granier C; Soussi T
Oncogene; 1998 Feb; 16(7):883-90. PubMed ID: 9484779
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
[TBL] [Abstract][Full Text] [Related]
20. p53 short peptide (p53pep164) regulates lipopolysaccharide-induced tumor necrosis factor-alpha factor/cytokine expression.
Tang X; Molina M; Amar S
Cancer Res; 2007 Feb; 67(3):1308-16. PubMed ID: 17283168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
